官方服务：
资源简介：
Instestinal organoids treated with either busulfan, fludarabine or clofarabine for 24hEGA dataset EGAD00001011336
应用场景：
创建时间：
2023-09-12
相关数据集
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
Precision oncology aims to improve clinical outcome of patients by offering personalized treatment through identifying druggable genomic aberrations within their tumors. This is particularly valid whe
NIAID Data Ecosystem60
Image-based profiling identifies compound induced phenotypes in patient-derived organoids
Patient derived organoids (PDOs) closely resemble individual tumor biology. They are thus promising models for drug discovery and precision medicine. Here, we describe high-throughput imaging and auto
NIAID Data Ecosystem60
Table_2_Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature.doc
Patients with non-small cell lung cancer (NSCLC) who carry epidermal growth factor receptor (EGFR) mutations can benefit significantly from EGFR tyrosine kinase inhibitors (EGFR TKIs). However, it is
NIAID Data Ecosystem30
Multivariate analysis of survival done with exact logistic regression in the cohort of 132 patients evaluated in the study.
Hazard ratio values are adjusted by score of cutaneous toxicity and number of previous chemotherapy lines. PFS: progression-free survival; OS: overall survival.
NIAID Data Ecosystem60
FORECAST 1. Feasibility of using Organoid Response to find Effective Treatments for patients with Colorectal cancer After failure of Standard Therapy
Interventions: This feasibility study involves the collection of fresh tumour tissue from patients with Metastatic Colorectal Cancer ( mCRC) for the purposes of establishing organoid model cultures.Pa
NIAID Data Ecosystem40
